Studi ed articoli recenti supportati dalla Fondazione APS - ONLUS
(in ordine cronologico inverso)
Bucci T, Ames PRJ, Cammisotto V, Bartimoccia S, Triggiani M, Parente R, Ciampa A, Pignatelli P, Carnevale R, Pastori D; ATHERO-APS Study Group. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study. J Autoimmunity 2022 May; 129: 102832.
Bucci T, Pastori D, Ames PRJ. REPLY to "Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome". J Thromb Thrombolysis. 2022 Jan 30. doi: 10.1007/s11239-021-02625-x.
Merashli M, Bucci T, Pastori D, Pignatelli P, Arcaro A, Gentile F, Marottoli V, Ames PRJ. Plasma Homocysteine in Behcet's Disease: A Systematic Review and Meta-Analysis. Thromb Haemost 2022 Jan 7. doi: 10.1055/s-0041-1740637.
Merashli M, Bucci T, Pastori D, Pignatelli P, Arcaro A, Gentile F, Marottoli V, Ames PRJ. A Meta-Analysis of Plasma Homocysteine in Buerger's Disease. Thromb Haemost 2022 Jan 20. doi: 10.1055/s-0041-1742165.
Bucci T, Ames PRJ, Triggiani M, Parente R, Ciampa A, Pignatelli P, Pastori D; Multicenter ATHERO-APS Study group. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study. Thromb Res 2022; 209: 69-74
Pastori D, Ames PRJ, Triggiani M, Ciampa A, Cammisotto V, Carnevale R, Pignatelli P, Bucci T, On Behalf Of The Athero-Aps Study Group. Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study. J Clin Med 2021; 10: 3180.
Isoprostane in systemic sclerosis: a systematic review and meta-analysis. Ames PRJ, Merashli M, Bucci T, Norouz-Zadeh J. Mod Rheumatol 2018:1-14.
Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome. Ames PRJ, Lopez LL, Merashli M, Matsuura E. Auto Immun Highlights 2018; 9:2
Oral anticoagulation cost in primary antiphospholipid syndrome: comparison between warfarin and hypothetical rivaroxaban. Ciampa A, Salapete C, Vivolo S, Ames PRJ. Blood Coagul Fibrinolysis 2018; 29: 135-138
Coagulation and complement in antiphospholipid syndrome. Ames PRJ, Alves JD, Gentile F. Thromb Res 2017; 158: 149-151
Clinical relevance of antiphospholipid antibodies in multiple sclerosis: a systematic review & meta-analysis. Merashli M, Delgado Alves J, Gentile F, Ames PRJ. Sem Arthritis Rheum 2017; 46: 810-818
Clinical relevance of antiphospholipid antibodies in systemic sclerosis: a systematic review & meta-analysis. Merashli M, Delgado Alves J, Ames PRJ. Sem Arthritis Rheum 2017; 46: 615-624
Survival in primary antiphospholipid syndrome. A single-centre cohort study. Ames PRJ, Merashli M, Chis Ster I, D'Andrea G, Iannaccone L, Marottoli V, Margaglione M, Brancaccio V. Thromb Haemost 2016, in corso di stampa
Incidental splanchnic vein thrombosis: preliminary registry data. Ames PRJ, Margaglione M. Lancet Haematology 2016; in corso di stampa
Subclinical atherosclerosis in Behcet'disease: a systematic review and meta-analysis. Merashli M, Ster IC, Ames PRJ. Sem Arthrit Rheum 2016;45:502-510
Ames PRJ, Guardascione M, Batuca JR, Arcaro A, Gentile F, Amitrano L. Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome. Scand J Gastroenterol 2015; 7:1-5
Prolonged Activated Partial Thromboplastin Time: Difficulties in Discriminating Coexistent Factor VIII Inhibitor and Lupus Anticoagulant. Ames PRJ, Graf M, Archer J, Scarpato N, Iannaccone L. Clin Appl Thromb Hemost 2015; 21:149-154
Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study. Sokoll KB, Batuca J, Lopez LR, Hensor E, Emery P, Delgado Alves J, Ames PRJ. Immunology 2014; ID 295239, doi:10.1155/2014/295239
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. Lopez LR, Guyer KE, Torre IG, Pitts KR, Matsuura E, Ames PRJ. World J Diabetes 2014; 5: 115-127
β2-Glycoprotein I and Oxidative Inflammation in Early Atherogenesis: A progression from Innate to Adaptive Immunity? Matsuura EE, Lopez LR, Shoenfeld Y, Ames PRJ. Autoimmunity Review 2012, 12: 241-249
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. Ames PRJ, Batuca JR, Muncy IJ, De La Torre IJ, Guyer K, Matsuura EE, Lopez LR. Thromb Res 2012, 130: 350-354
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Ames PRJ, Margaglione M, Ciampa A, Colaizzo D, Ferrara F, Iannaccone L, Brancaccio V. Thromb Res 2011; 127: 595-599
Thrombophilia and eosinophilia in Churg Strauss syndrome: a clinical and pathogenetic overview. Ames PRJ, Margaglione M, Mackie S, Delgado Alves J. Clin Appl Thromb Hemost 2010; 16: 628-636
Rosuvastatin decreases serum oxidised low-density lipoprotein/beta-2-glycoprotein I in type 2 diabetes: a possible antioxidant effect of the drug? Ames PRJ, Ortiz-Cadenas A, Garcia-De La Torre I et al. Br J Diab Vasc Dis 2010; 10: 292-299
Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome. Ames PRJ, Batuca JR, Ciampa A, Delgado Alves J. J Rheum 2010; 37: 2523-2530
High density lipoprotein inversely relates to its specific antibody favouring oxidation in thrombotic primary antiphospholipid sindrome. Ames PRJ, Matsuura EE, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Delgado Alves J. Lupus 2010; 19: 711-6
Atherosclerosis in thrombotic primary antiphospholipid syndrome. Ames PRJ, Scenna G, Antinolfi I, Gaeta G, Margaglione M, Margarita A. J Thromb Haemost 2009; 7: 537-542
Anti-atherogenic and anti-inflammatory properties of high density lipoprotein are affected by specific antibodies in systemic lupus erythematosus. Batuca J, Ames PRJ, Amaral M, Favas C, Isenberg DA, Delgado Alves J. Rheumatology 2009; 48: 26-31
